Status:
COMPLETED
Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately
Lead Sponsor:
AstraZeneca
Conditions:
Peptic Ulcer Disease
Eligibility:
All Genders
20-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to investigate whether treatment with a combination capsule of Esomeprazole 40 mg and Aspirin (ASA) 325 mg is bioequivalent (i.e.has the same effect within the body) as th...
Eligibility Criteria
Inclusion
- Non-smoking male or female within the age range of 20 to 50 years
- Body Mass Index (BMI = weight/height2) greater than or equal to 18.5 kg/m2 and less than or equal to 29.9 kg/m2
Exclusion
- Documented upper gastrointestinal surgery
- Use of any proton pump inhibitors or any bismuth preparations (e.g. Pepto-Bismol®) within 14 days preceding the screening visit
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT00998075
Start Date
September 1 2009
End Date
December 1 2009
Last Update
December 7 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Scarborough Village, Ontario, Canada